PepGen

PepGen Graham Number

The Graham Number of PepGen (PEPG) as of Nov 19, 2026 is 12.87 USD. In the previous year, Graham Number was 14.95 USD — a change of -13.91% (lower).

Graham Number

12.87USD

YoY

-13.91%

Last updated:

Graham Number of PepGen is 2025 12.87 USD. Graham Number of PepGen was 2024 14.95 USD. It decreases by -13.91% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PepGen Stock analysis

What does PepGen do? PepGen Inc., based in Cambridge, Massachusetts, is a biotechnology company focused on developing oligonucleotide therapies for neuromuscular and neurologic diseases. The company utilizes its enhanced delivery oligonucleotide (EDO) platform, which employs cell-penetrating peptides to enhance therapeutic delivery. Its lead candidates, PGN-EDO51 for Duchenne muscular dystrophy and PGN-EDODM1 for myotonic dystrophy type 1, are part of a pipeline targeting degenerative conditions. Listed on 6 May 2022, PepGen operates with a team of 56 employees. PepGen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PepGen stock

Graham Number of PepGen is 12.87 USD in 2025.

On Eulerpool you can find the complete historical development of Graham Number PepGen since 2006 – with annual values, charts, and detailed analysis.

The Graham Number estimates the maximum fair price for a stock based on EPS and book value per share, following Benjamin Graham's value investing principles.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — PepGen

All Key Metrics — PepGen